Pfizer And Flagship Alliance Seeks Faster R&D Paradigm For Novel Meds

 
• By Joseph Haas

The two partners are committing $100m to a 10-program effort combining Pfizer’s R&D capabilities with technologies and modalities housed within Flagship Pioneering and its portfolio companies.

Flagship
Flagship will partner with Pfizer to develop 10 novel medicines • Source: Shutterstock

More from Strategy

More from Business